tirzepatide weight loss mechanism of action Frontiers How Does Tirzepatide Work For

Patients monitoring side effects and efficacy every four weeks with their provider are better positioned to reach a stable maintenance dose without unnecessary discomfort

Semaglutide is FDA-approved for adults with a BMI of 30 or higher (obese), or a BMI of 27 or higher (overweight) with at least one weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol

The ethical and public health concerns surrounding weight-loss drugs are valid and should be carefully considered alongside the potential economic opportunities

For women, menstrual cycle changes that occurred during treatment, including increased fertility, heavier or lighter periods, or timing shifts, may continue changing after discontinuation